Research and Innovation

Four UCL Great Ormond Street Institute of Child Health researchers have been awarded research grants from Great Ormond Street Hospital Children’s Charity and Sparks, the children’s medical research charity as part of their annual National Call. 

Two allied health professionals (AHPs) at Great Ormond Street Hospital (GOSH) have been awarded prestigious Clinical Doctoral Fellowships from the National Institute for Health Research (NIHR).

GOSH nurse Dr Kate Oulton is to become part of a brand new nurse and midwife research leadership programme - the National Institute for Health Research’s (NIHR) 70@70 Research Leader programme.

Genetic sequencing improved the diagnosis of abnormalities detected in ultrasound scans of developing babies, in new research from Great Ormond Street Hospital (GOSH), the Wellcome Sanger Institute and Birmingham Women’s Hospital.

An 11-year-old boy has become the first NHS patient to receive a pioneering new cancer therapy at Great Ormond Street Hospital (GOSH).

A new, targeted treatment for the rare form of rickets called X-Linked Hypophosphataemia (XLH) is now available to NHS patients from 8 January 2019, following an international clinical trial.

Professor Bobby Gaspar, who has pioneered gene therapy research at Great Ormond Street Hospital (GOSH) for the last 20 years, was a special guest at the Royal Institution Christmas lectures this year. 

A whole host of exciting scientific discoveries have been made at Great Ormond Street Hospital (GOSH) and the UCL Institute of Child Health (ICH). We’re unwrapping our biggest discoveries from the last 12 months.

In celebration of the Year of Zayed, Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH) welcomed a delegation from the Government of Abu Dhabi this week. This year celebrates 100 years since the birth of the late Sheikh Zayed bin Sultan Al Nahyan, Founding Father of the UAE. 

Researchers at Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH) are to lead a new collaboration exploring how stem cells can be engineered to evade immune responses.